Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients

por Janssen, M. A. M., Bosch, M., Koopmans, P. P., Kessels, R. P. C.
Publicado 2015

Differences in Cortical Sources of the Event-Related P3 Potential Between Young and Old Participants Indicate Frontal Compensation

por van Dinteren, R., Huster, R. J., Jongsma, M. L. A., Kessels, R. P. C., Arns, M.
Publicado 2017

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

por van den Berg, E., Reijmer, Y. D., de Bresser, J., Kessels, R. P. C., Kappelle, L. J., Biessels, G. J.
Publicado 2009

The effect of an interactive cycling training on cognitive functioning in older adults with mild dementia: study protocol for a randomized controlled trial

por Karssemeijer, E. G. A., Bossers, W. J. R., Aaronson, J. A., Kessels, R. P. C., Olde Rikkert, M. G. M.
Publicado 2017

The Course of Cognitive Performance during Inpatient Treatment in Patients with Alcohol Use Disorder with No, Mild or Major Neurocognitive Disorders

por Bruijnen, C J W H, Walvoort, S J W, Dijkstra, B A G, de Jong, C A J, Kessels, R P C
Publicado 2020

Baseline white matter microstructural integrity is not related to cognitive decline after 5 years: The RUN DMC study

por van Uden, I.W.M., van der Holst, H.M., Schaapsmeerders, P., Tuladhar, A.M., van Norden, A.G.W., de Laat, K.F., Norris, D.G., Claassen, J.A.H.R., van Dijk, E.J., Richard, E., Kessels, R.P.C., de Leeuw, F.-E.
Publicado 2015

Impaired Knowledge of Social Norms in Dementia and Psychiatric Disorders: Validation of the Social Norms Questionnaire–Dutch Version (SNQ-NL)

por van den Berg, E., Poos, J. M., Jiskoot, L. C., Montagne, B., Kessels, R. P. C., Franzen, S., van Hemmen, J., Eikelboom, W. S., Heijboer, E. G. C., de Kriek, J., van der Vlist, A., de Jong, F. J., van Swieten, J. C., Seelaar, H., Papma, J. M.
Publicado 2021

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/II...

por Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., Henderickx, J. G. E., Keller, J. J., Verspaget, H. W., Kuijper, E. J., Haanen, J. B. A. G.
Publicado 2022

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

por Rohaan, M.W., Gomez-Eerland, R., van den Berg, J.H., Geukes Foppen, M.H., van Zon, M., Raud, B., Jedema, I., Scheij, S., de Boer, R., Bakker, N.A.M., van den Broek, D., Pronk, L.M., Grijpink-Ongering, L.G., Sari, A., Kessels, R., van den Haak, M., Mallo, H.A., Karger, M., van de Wiel, B.A., Zuur, C.L., Duinkerken, C.W., Lalezari, F., van Thienen, J.V., Wilgenhof, S., Blank, C.U., Beijnen, J.H., Nuijen, B., Schumacher, T.N., Haanen, J.B.A.G.
Publicado 2022